Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Sindall Group Regulatory News (MGNS)

Share Price Information for Morgan Sindall Group (MGNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,465.00
Bid: 2,455.00
Ask: 2,465.00
Change: 10.00 (0.41%)
Spread: 10.00 (0.407%)
Open: 2,435.00
High: 2,465.00
Low: 2,425.00
Prev. Close: 2,455.00
MGNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

7 Mar 2017 10:39

RNS Number : 7428Y
Morgan Sindall Group PLC
07 March 2017
 

MORGAN SINDALL GROUP plc

(the "Company")

 

Notification of Transactions by Directors

 

The Morgan Sindall 2014 Long Term Incentive Plan (the Plan)

 

Grant of conditional share awards

On 6 March 2017, certain directors of the Company were granted conditional share awards over ordinary shares of 5p each in the capital of the Company ("shares") under the Morgan Sindall 2014 Long Term Incentive Plan ("the Plan").

 

Details of the directors and the number of shares under conditional share awards granted to them under the Plan are set out below:

 

Director

Number of conditional shares awarded

John Morgan

72,636

Steve Crummett

57,918

 

Conditional share awards will normally vest on 6 March 2020 being the third anniversary of the date of grant, subject to continued employment with the Company and satisfaction of the following performance conditions, which are measured over a period of three financial years ending on 31 December 2019:

 

· the number of shares under award representing 100% of the relevant director's salary will be based on a performance condition measuring the Company's earnings per share (EPS). EPS will be expressed in cumulative pence terms and will be equivalent to a growth rate of 6-13% per year over the three-year period; and

 

· the number of shares under award representing 50% of the relevant director's salary will be based on a performance condition measuring the Company's total shareholder return ("TSR") compared with seven of its UK listed peers. TSR will be expressed as an outperformance of median TSR with full vesting for the TSR component requiring 10% per year outperformance of the comparator median.

 

Depending on whether or not the performance conditions are met the directors will receive between 0% and 100% of the award. Details of the performance conditions will be set out in the Directors' Remuneration Report in the Company's 2016 Annual Report (which will be published on or about 27 March 2017).

 

These awards will be subject to a two year holding period on vesting. The base price for calculating the number of conditional shares award was £10.13, the average closing share price between 27 February 2017 and 3 March 2017.

 

No consideration was paid for the grant of the awards.

 

Following the grant of the conditional share awards under the Plan these directors maintain the following beneficial interests in the issued share capital of the Company:

 

Director

Beneficial interest in the shares of the Company

% of the issued share capital of the Company

Total number of shares over which options are held

Total number of conditional share awards held

John Morgan

4,504,352

10.07

106,364

320,630

Steve Crummett

14,615

 0.03

 Nil

248,877

 

This notification relates to transactions notified in accordance with both Disclosure Rule 3.1.4R (1) (a) and Disclosure Rule 3.1.4R (1) (c).

 

 

Contact:

 

Clare Sheridan Tel: 020 7307 9200

Company Secretary

7 March 2017

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHLLFVIVTIDIID
Date   Source Headline
4th Jun 20184:34 pmRNSHolding(s) in Company
1st Jun 20184:30 pmRNSTotal Voting Rights
16th May 20188:00 amRNSAdditional Listing
4th May 201812:37 pmRNSResult of AGM
4th May 20187:00 amRNSAGM Trading Update
30th Apr 201810:17 amRNSTotal Voting Rights
23rd Apr 20189:15 amRNSBlock listing Interim Review
17th Apr 20187:00 amRNSMorgan Sindall Group Agrees £2bn Joint Venture
29th Mar 20185:29 pmRNSTotal Voting Rights
26th Mar 201812:25 pmRNSAnnual Financial Report
20th Mar 20182:38 pmRNSHolding(s) in Company
7th Mar 20189:28 amRNSDirector/PDMR Shareholding
7th Mar 20189:27 amRNSDirector/PDMR Shareholding
5th Mar 20183:49 pmRNSDirector/PDMR Shareholding
28th Feb 201811:19 amRNSTotal Voting Rights
26th Feb 20189:43 amRNSHolding(s) in Company
22nd Feb 20187:00 amRNSFinal Results
1st Feb 201810:45 amRNSTotal Voting Rights
30th Jan 20182:33 pmRNSHolding(s) in Company
29th Jan 20183:10 pmRNSDirectorate Change
15th Jan 201812:38 pmRNSStatement re: Carillion plc
8th Jan 20187:00 amRNSNotice of Results
3rd Jan 20189:08 amRNSTotal Voting Rights
14th Dec 20178:00 amRNSAdditional Listing
1st Dec 20171:00 pmRNSTotal Voting Rights
1st Dec 201712:37 pmRNSDirector/PDMR Shareholding
28th Nov 20175:13 pmRNSHolding(s) in Company
27th Nov 20177:00 amRNSPartnership Homes MOD Contract
24th Nov 20172:55 pmRNSHolding(s) in Company
22nd Nov 20177:00 amRNSAnalyst and Investor Evening Reception
2nd Nov 201712:50 pmRNSHolding(s) in Company
1st Nov 20177:00 amRNSTrading Update
31st Oct 20172:03 pmRNSTotal Voting Rights
27th Oct 201710:00 amRNSNotice of Trading Update
23rd Oct 20178:47 amRNSBlock listing Interim Review
2nd Oct 20179:05 amRNSTotal Voting Rights
21st Sep 20178:00 amRNSAdditional Listing
8th Sep 20173:27 pmRNSHolding(s) in Company
6th Sep 20175:22 pmRNSHolding(s) in Company
31st Aug 201712:16 pmRNSTotal Voting Rights
17th Aug 20171:14 pmRNSHolding(s) in Company
17th Aug 201711:12 amRNSHolding(s) in Company
8th Aug 20177:00 amRNSHalf-year Report
4th Aug 20178:45 amRNSHolding(s) in Company
31st Jul 201712:27 pmRNSTotal Voting Rights
19th Jul 20177:00 amRNSTrading Update
3rd Jul 20174:54 pmRNSHolding(s) in Company
3rd Jul 201710:31 amRNSTotal Voting Rights
23rd Jun 20177:00 amRNSNotice of Results
20th Jun 20177:00 amRNSMorgan Sindall contract extension worth up to £60m

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.